跳至主要内容
临床试验/RPCEC00000342
RPCEC00000342已完成未知

Observational study of the benefits of rectal ozonotherapy and BIOPLA as complementary therapy in convalescent patients with SARS-COV 2 (COVID-19) - EST-OBS-OZO-BIOPLA-SARS-COV 2

ational Center for Scientific Research0 个研究点目标入组 40 人开始时间: 2020年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Hospitalization patients convalescient with SARS-CoV 2, bewteen 40 and 80 years , both sexes, signed informed consent.

排除标准

  • 1) Patients with uncontrolled hypertiroidism
  • 2) Patients with deficit of glucose-6-phosphateo-deshidrogenase
  • 3) Non transmissible cronic diseases
  • 4) Oncological patients
  • 5) Patients with psiquiatric diseases
  • 6) Surgery
  • 7) Patients use inmunosupresant or patients with trasplant
  • 8) Patiens with coagulation , trombocitopenia or active bleed
  • 9) Allergic patients
  • 10) Patients participate in other clinical trials 3 months before

研究者

发起方
ational Center for Scientific Research

相似试验